Inhibition of adenosine A2A receptor (A2AR) by CPI-444 enhances CD8+T cell killing of a HER-2/neu expressing murine tumor

被引：2
|
作者：
Scott, Blake A.
Armstrong, Todd
Jaffee, Elizabeth M.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-320
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
320
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Effective induction of CD8+T-cell response using CpG oligodeoxynucleotides and HER-2/neu-derived peptide co-encapsulated in liposomes
    Li, WM
    Dragowska, WH
    Bally, MB
    Schutze-Redelmeier, MP
    VACCINE, 2003, 21 (23) : 3319 - 3329
  • [42] CD4+ T-Helper Type 1 Cytokines and Trastuzumab Facilitate CD8+ T-cell Targeting of HER2/neu-Expressing Cancers
    Datta, Jashodeep
    Xu, Shuwen
    Rosemblit, Cinthia
    Smith, Jenessa B.
    Cintolo, Jessica A.
    Powell, Daniel J., Jr.
    Czerniecki, Brian J.
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (05) : 455 - 463
  • [43] Inhibition of the adenosine A2a receptor modulates expression of T cell coinhibitory receptors and improves effector function for enhanced checkpoint blockade and ACT in murine cancer models
    Robert D. Leone
    Im-Meng Sun
    Min-Hee Oh
    Im-Hong Sun
    Jiayu Wen
    Judson Englert
    Jonathan D. Powell
    Cancer Immunology, Immunotherapy, 2018, 67 : 1271 - 1284
  • [44] Inhibition of the adenosine A2a receptor modulates expression of T cell coinhibitory receptors and improves effector function for enhanced checkpoint blockade and ACT in murine cancer models
    Leone, Robert D.
    Sun, Im-Meng
    Oh, Min-Hee
    Sun, Im-Hong
    Wen, Jiayu
    Englert, Judson
    Powell, Jonathan D.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (08) : 1271 - 1284
  • [45] HSP90 inhibitor 17-DMAG enhances EphA2+tumor cell recognition by specific CD8+T cells
    Kawabe, Mayumi
    Mandic, Maja
    Taylor, Jennifer
    Vasquez, Cecilia
    Wesa, Amy
    Neckers, Leonard
    Storkus, Walter
    JOURNAL OF IMMUNOLOGY, 2009, 182
  • [46] Vaccination strategy determines the emergence and dominance of CD8+ T-cell epitopes in a FVB/N rat HER-2/neu mouse model of breast cancer
    Singh, Reshma
    Paterson, Yvonne
    CANCER RESEARCH, 2006, 66 (15) : 7748 - 7757
  • [47] A HER2/NEU-derived peptide, a Kd-restricted murine tumor rejection antigen, induces HER2-specific HLA-A2402-restricted CD8+ cytotoxic T lymphocytes
    Ikuta, Y
    Okugawa, T
    Furugen, R
    Nagata, Y
    Takahashi, Y
    Wang, LJ
    Ikeda, H
    Watanabe, M
    Imai, S
    Shiku, H
    INTERNATIONAL JOURNAL OF CANCER, 2000, 87 (04) : 553 - 558
  • [48] DNA vaccine co-expressing Her2/ErbB2 antigen, fused with LAMP, elicits strong antitumor effects in vivo by increasing tumor infiltration with CD8+T cells
    Xu, Renhuan
    Heiland, Teri
    CANCER RESEARCH, 2019, 79 (13)
  • [49] Istradefylline, an adenosine A2a receptor antagonist, inhibits the CD4+ T-cell hypersecretion of IL-17A and IL-8 in humans
    Tokano, Mieko
    Kawano, Masaaki
    Takagi, Rie
    Matsushita, Sho
    IMMUNOLOGICAL MEDICINE, 2022, 45 (04) : 244 - 250
  • [50] CD4+ and CD8+ neu-reactive T cells are sensitized by breast cancer stem-like cells (BCSC) in tolerized Her-2/neu transgenic mice and can mediate tumor regression upon adoptive transfer
    Wang, Li-Xin
    Koski, Gary K.
    Plautz, Gregory E.
    CANCER RESEARCH, 2010, 70
12345